ERS Position Paper on Tobacco Harm Reduction

ERS Tobacco Control Committee

Source: Guideline 2019
Number: 2019

PDF journal article, handout or slides

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
ERS Tobacco Control Committee. ERS Position Paper on Tobacco Harm Reduction. Guideline 2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Tobacco Smoking: Harm Reduction Strategies - An ERS Research Seminar
Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies
Year: 2005

Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021

Assessment of Compliance to Framework Convention on Tobacco Control in Turkey
Source: International Congress 2017 – Global epidemiologic data on smoking
Year: 2017

LATE-BREAKING ABSTRACT: Particle Emission of e-cigarette
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014

Harm reduction strategies for tobacco smoking: report from an ERS Research Seminar
Source: ISSN=ISSN 1810-6838, ISBN=, page=302
Year: 2006

Relation Between Respiratory Function, Tobacco Consumption, Exercise Habits, and Sleep Quality in Healthy Young Adult Men
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020

Influence of Smoking, Environmental  Factors and Life Style on Lung Function in a Large German Cohort
Source: International Congress 2018 – Occupational and environmental lung diseases: inhaled air quality and health effects
Year: 2018

Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020

LATE-BREAKING ABSTRACT: Pulmonary Function Abnormalities among Adolescent Street Children Smokers In Indonesia
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

In the spotlight: Early Career Member Awardee 2020, ERS Lung Science Conference 2021, and Sleep and Breathing 2021
Source: Breathe, 16 (4) 200199; 10.1183/20734735.0199-2020
Year: 2020

The WHO–ERS Smoking Cessation Training Project: the first year of experience
Source: ERJ Open Res, 4 (3) 00070-2018; 10.1183/23120541.00070-2018
Year: 2018

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017
Year: 2017

Paediatric Assembly: Lifetime Achievement Awardee Introduction
Source: Annual Congress 2010 - Paediatric Year in Review
Year: 2010

Determination of Attitudes of Turkish Thoracic Society Members on Exposure to Sexist Approach and Sexism in Business Life
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018

Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group.
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018

Socioeconomic Status and Cleaning: Major Factors Affecting Asthma Control
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020

Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019